Consumer News Weight Loss Drug Zepbound Is Also Effective For Sleep Apnea, Study Finds

FDA approves weight loss drug Zepbound for sleep apnea

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said. Read More

Weight-loss drugs are changing. Here’s what to know

Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds experience dramatic weight loss on the medications, and there are indications that ... Read More

FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.

The weekly injection is now the first drug treatment option cleared for patients with obesity and moderate-to-severe obstructive sleep apnea, or OSA, which refers to breathing interrupted during sleep ... Read More

Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too

The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from a large-scale trial show they can treat sleep apnea. Read More

Pill Forms of Wegovy and Zepbound Are Expected To Increase Weight-Loss Market, but High Costs Are a Concern

The first pills are expected to hit the market next month and attract people who don’t want to give themselves shots. Read More

Zepbound Maker Eli Lilly Reports Patients Achieved Dramatic Weight Loss in Study of Newest Obesity Drug

Eli Lilly and Company says the highest doses of its next-generation weight loss drug helped patients lose an average of 28.7 percent of their body weight in a new study, significantly more than its ... Read More

Zepbound vs. Wegovy: Which Obesity Treatment Might Be Right for You?

There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) have been making headlines lately. They’re two of the few injectable medications approved specifically for ... Read More

New weight-loss shot shows major fat reduction, but experts urge caution

An experimental medication was shown to help boost weight loss by up to 20%, a study found. Eloralintide, a once-weekly injectable manufactured by Eli Lilly in Indianapolis, led to "meaningful, ... Read More

Major weight loss, pain relief seen with Eli Lilly's next-gen drug in late-stage trial

A new weight-loss drug that Eli Lilly is testing is helping patients in a late-stage trial lose an average of 28.7% of their body weight and offered "substantial" relief from osteoarthritis pain. In ... Read More